Journal of Virology, May 2001, p. 4918-4921, Vol. 75, No. 10
0022-538X/01/$04.00+0 DOI: 10.1128/JVI.75.10.4918-4921.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Division of Virology, Institute of Biomolecular and Life Sciences, University of Glasgow, Glasgow,1 and AMS, The University of Reading, Whiteknights, Reading RG6 5AJ,2 United Kingdom
Received 6 November 2000/Accepted 7 February 2001
Some echoviruses (EV) that bind decay-accelerating factor (DAF) also bind cells of human and murine origins in a DAF-independent manner. Pretreatment of cells with heparinase 1 or heparin blocks the binding of radiolabeled virus to the cell surface, and heparin prevents infection of rhabdomyosarcoma cells by certain EV, including several low-passage clinical isolates of EV 6 and some EV that do not bind DAF. These studies suggest that heparan sulfate may be of in vivo relevance as an attachment molecule for EV.
This article has been cited by other articles:
| J. Bacteriol. | Mol. Cell. Biol. | Microbiol. Mol. Biol. Rev. |
|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|